Molecular epidemiology of penicillin-resistant and ciprofloxacin-resistant Streptococcus pneumoniae in CanadaNICHOL, Kimberly A; ZHANEL, George G; HOBAN, Daryl J et al.Antimicrobial agents and chemotherapy. 2003, Vol 47, Num 2, pp 804-808, issn 0066-4804, 5 p.Article

Antimicrobial susceptibility of extended-spectrum β-lactamase producers and multidrug-resistant Acinetobacter baumannii throughout the United States and comparative in vitro activity of tigecycline, a new glycylcycline antimicrobialHOBAN, Daryl J; BOUCHILLON, Samuel K; DOWZICKY, Michael J et al.Diagnostic microbiology and infectious disease. 2007, Vol 57, Num 4, pp 423-428, issn 0732-8893, 6 p.Article

Penicillin-binding protein 1A, 2B, and 2X alterations in Canadian isolates of penicillin-resistant Streptococcus pneumoniaeNICHOL, Kimberly A; ZHANEL, George G; HOBAN, Daryl J et al.Antimicrobial agents and chemotherapy. 2002, Vol 46, Num 10, pp 3261-3264, issn 0066-4804, 4 p.Article

Nitrofurantoin is active against vancomycin-resistant enterococciZHANEL, George G; HOBAN, Daryl J; KARLOWSKY, James A et al.Antimicrobial agents and chemotherapy. 2001, Vol 45, Num 1, pp 324-326, issn 0066-4804Article

Comparison of gatifloxacin and levofloxacin administered at various dosing regimens to hospitalised patients with community-acquired pneumonia : pharmacodynamic target attainment study using North American surveillance data for Streptococcus pneumoniaeNOREDDIN, Ayman M; HOBAN, Daryl J; ZHANEL, George G et al.International journal of antimicrobial agents. 2005, Vol 26, Num 2, pp 120-125, issn 0924-8579, 6 p.Article

Characterization of plasmids encoding CMY-2 AmpC β-lactamases from Escherichia coli in Canadian intensive care unitsBAUDRY, Patricia J; MATASEJE, Laura; ZHANEL, George G et al.Diagnostic microbiology and infectious disease. 2009, Vol 65, Num 4, pp 379-383, issn 0732-8893, 5 p.Article

Genetic relatedness of multidrug-resistant Escherichia coli cultured from geographically diverse outpatient, midstream urine specimensKARLOWSKY, James A; KASLOFF, Sam; NICHOL, Kim A et al.Diagnostic microbiology and infectious disease. 2007, Vol 58, Num 3, pp 283-287, issn 0732-8893, 5 p.Article

Comparative Pharmacodynamics of Garenoxacin, Gemifloxacin, and Moxifloxacin in Community-Acquired Pneumonia Caused by Streptococcus pneumoniae : A Monte Carlo Simulation AnalysisNOREDDIN, Ayman M; REESE, Angela A; OSTROSKI, Melissa et al.Clinical therapeutics. 2007, Vol 29, Num 12, pp 2685-2689, issn 0149-2918, 5 p.Article

Mutant prevention concentrations for single-step fluoroquinolone-resistant mutants of wild-type, efflux-positive, or ParC or GyrA mutation-containing Streptococcus pneumoniae isolatesSMITH, Heather J; WALTERS, Michael; HISANAGA, Tamiko et al.Antimicrobial agents and chemotherapy. 2004, Vol 48, Num 10, pp 3954-3958, issn 0066-4804, 5 p.Article

Macrolide-resistant Streptococcus pneumoniae in Canada during 1998-1999 : Prevalence of mef(A) and erm(B) and susceptibilities to ketolidesHOBAN, Daryl J; WIERZBOWSKI, Aleksandra K; NICHOL, Kim et al.Antimicrobial agents and chemotherapy. 2001, Vol 45, Num 7, pp 2147-2150, issn 0066-4804Article

Rising incidence of Staphylococcus aureus with reduced susceptibility to vancomycin and susceptibility to antibiotics: a global analysis 2004-2009HAWSER, Stephen P; BOUCHILLON, Samuel K; HOBAN, Daryl J et al.International journal of antimicrobial agents (Print). 2011, Vol 37, Num 3, pp 219-224, issn 0924-8579, 6 p.Article

Pathogen of occurrence and susceptibility patterns associated with pneumonia in hospitalized patients in North America: results of the SENTRY Antimicrobial Surveillance Study (2000)HOBAN, Daryl J; BIEDENBACH, Douglas J; MUTNICK, Alan H et al.Diagnostic microbiology and infectious disease. 2003, Vol 45, Num 4, pp 279-285, issn 0732-8893, 7 p.Article

Stretching the mutant prevention concentration (MPC) beyond its limitsSMITHS, Heather J; NICHOL, Kimberly A; HOBAN, Daryl J et al.Journal of antimicrobial chemotherapy (Print). 2003, Vol 51, Num 6, pp 1323-1325, issn 0305-7453, 3 p.Article

Stability of fluoroquinolone resistance in Streptococcus pneumoniae clinical isolates and laboratory-derived mutantsSMITH-ADAM, Heather J; NICHOL, Kimberly A; HOBAN, Daryl J et al.Antimicrobial agents and chemotherapy. 2005, Vol 49, Num 2, pp 846-848, issn 0066-4804, 3 p.Article

Molecular characterization of fluoroquinolone resistant Streptococcus pneumoniae clinical isolates obtained from across CanadaZHANEL, George G; WALKTY, Andrew; NICHOL, Kim et al.Diagnostic microbiology and infectious disease. 2003, Vol 45, Num 1, pp 63-67, issn 0732-8893, 5 p.Article

Susceptibility of Staphylococcus aureus to Topical Agents in the United States: A Sentinel StudyBIEDENBACH, Douglas J; BOUCHILLON, Samuel K; JOHNSON, Seth A et al.Clinical therapeutics. 2014, Vol 36, Num 6, pp 953-960, issn 0149-2918, 8 p.Article

AFN-1252, a FabI Inhibitor, Demonstrates a Staphylococcus-Specific Spectrum of ActivityKARLOWSKY, James A; KAPLAN, Nachum; HAFKIN, Barry et al.Antimicrobial agents and chemotherapy. 2009, Vol 53, Num 8, pp 3544-3548, issn 0066-4804, 5 p.Article

A review of clinical failures associated with macrolide-resistant Streptococcus pneumoniaeRZESZUTEK, Marek; WIERZBOWSKI, Aleksandra; HOBAN, Daryl J et al.International journal of antimicrobial agents. 2004, Vol 24, Num 2, pp 95-104, issn 0924-8579, 10 p.Article

Influence of human serum on antifungal pharmacodynamics with Candida albicansZHANEL, George G; SAUNDERS, David G; HOBAN, Daryl J et al.Antimicrobial agents and chemotherapy. 2001, Vol 45, Num 7, pp 2018-2022, issn 0066-4804Article

In vitro activity of ceftobiprole against frequently encountered aerobic and facultative Gram-positive and Gram-negative bacterial pathogens: results of the CANWARD 2007-2009 study : CANWARD SYMPOSIUMWALKTY, Andrew; ADAM, Heather J; LAVERDIERE, Michel et al.Diagnostic microbiology and infectious disease. 2011, Vol 69, Num 3, pp 348-355, issn 0732-8893, 8 p.Article

Incidence and Antimicrobial Susceptibility of Escherzchia coli and Klebsiella pneumoniae with Extended-Spectrum β-Lactamases in Community- and Hospital-Associated Intra-Abdominal Infections in Europe: Results of the 2008 Study for Monitoring Antimicrobial Resistance Trends (SMART)HAWSER, Stephen P; BOUCHILLON, Samuel K; HOBAN, Daryl J et al.Antimicrobial agents and chemotherapy. 2010, Vol 54, Num 7, pp 3043-3046, issn 0066-4804, 4 p.Article

Increasing Genetic Relatedness of Ciprofloxacin-Resistant Streptococcus pneumoniae Isolated in Canada from 1997 to 2005NICHOL, Kimberly A; ADAM, Heather J; KARLOWSKY, James A et al.Antimicrobial agents and chemotherapy. 2008, Vol 52, Num 3, pp 1190-1194, issn 0066-4804, 5 p.Article

Pharmacodynamic activity of garenoxacin against ciprofloxacin-resistant Streptococcus pneumoniaeZHANEL, George G; JAMES, Joanne; DERKATCH, Sheldon et al.Journal of antimicrobial chemotherapy (Print). 2006, Vol 58, Num 1, pp 112-116, issn 0305-7453, 5 p.Article

Molecular epidemiology of urinary tract isolates of vancomycin-resistant Enterococcus faecium from North AmericaNICHOL, Kimberly A; SILL, Michelle; LAING, Nancy M et al.International journal of antimicrobial agents (Print). 2006, Vol 27, Num 5, pp 392-396, issn 0924-8579, 5 p.Article

Molecular epidemiology and prevalence of macrolide efflux genes mef(A) and mef(E) in Streptococcus pneumoniae obtained in Canada from 1997 to 2002WIERZBOWSKI, Aleksandra K; SWEDLO, Dean; BOYD, Dave et al.Antimicrobial agents and chemotherapy. 2005, Vol 49, Num 3, pp 1257-1261, issn 0066-4804, 5 p.Article